title: Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study.
abstract: BACKGROUND
  Diethylstilbestrol (DES), a synthetic estrogen widely prescribed to pregnant women during the 1940s70s, has been shown to cause reproductive problems in the daughters. Studies of prenatally-exposed males have yielded conflicting results.
  
  
  METHODS
  In data from a collaborative follow-up of three U.S. cohorts of DES-exposed sons, we examined the relation of prenatal DES exposure to occurrence of male urogenital abnormalities. Exposure status was determined through review of prenatal records. Mailed questionnaires (1994, 1997, 2001) asked about specified abnormalities of the urogenital tract. Risk ratios (RR) were estimated by Cox regression with constant time at risk and control for year of birth.
  
  
  RESULTS
  Prenatal DES exposure was not associated with varicocele, structural abnormalities of the penis, urethral stenosis, benign prostatic hypertrophy, or inflammation/infection of the prostate, urethra, or epididymus. However, RRs were 1.9 (95% confidence interval 1.13.4) for cryptorchidism, 2.5 (1.54.3) for epididymal cyst, and 2.4 (1.54.4) for testicular inflammation/infection. Stronger associations were observed for DES exposure that began before the 11th week of pregnancy: RRs were 2.9 (1.65.2) for cryptorchidism, 3.5 (2.06.0) for epididymal cyst, and 3.0 (1.75.4) for inflammation/infection of testes.
  
  
  CONCLUSIONS
  These results indicate that prenatal exposure to DES increases risk of male urogenital abnormalities and that the association is strongest for exposure that occurs early in gestation. The findings support the hypothesis that endocrine disrupting chemicals may be a cause of the increased prevalence of cryptorchidism that has been seen in recent years.
authors.affiliation: Slone Epidemiology Center of Boston University, Boston, MA, USA. jpalmer@bu.edu
authors.forename: Julie R
authors.initials: JR
authors.lastname: Palmer
authors.forename: Arthur L
authors.initials: AL
authors.lastname: Herbst
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: Noller
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Boggs
authors.forename: Rebecca
authors.initials: R
authors.lastname: Troisi
authors.forename: Linda
authors.initials: L
authors.lastname: Titus-Ernstoff
authors.forename: Elizabeth E
authors.initials: EE
authors.lastname: Hatch
authors.forename: Lauren A
authors.initials: LA
authors.lastname: Wise
authors.forename: William C
authors.initials: WC
authors.lastname: Strohsnitter
authors.forename: Robert N
authors.initials: RN
authors.lastname: Hoover
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D000328:Adult; D015331:Cohort Studies; D003456:Cryptorchidism / Q000139:chemically induced / Q000453:epidemiology; D004054:Diethylstilbestrol / Q000009:adverse effects*; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D008875:Middle Aged; D009679:Nuclear Family; D016017:Odds Ratio; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced* / Q000453:epidemiology; D016016:Proportional Hazards Models; D012306:Risk; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology; D014564:Urogenital Abnormalities / Q000139:chemically induced* / Q000453:epidemiology; D055815:Young Adult
chemical_list: D004968:Estrogens, Non-Steroidal; D004054:Diethylstilbestrol
references.citation: J Urol. 1977 Feb;117(2):220-2
references.pmid: 833973
references.citation: Br J Cancer. 1996 Mar;73(5):698-701
references.pmid: 8605110
references.citation: Am J Obstet Gynecol. 1984 Jan 1;148(1):59-66
references.pmid: 6691382
references.citation: Hum Reprod. 2001 May;16(5):972-8
references.pmid: 11331648
references.citation: J Epidemiol Community Health. 1987 Jun;41(2):127-9
references.pmid: 2888831
references.citation: Environ Health Perspect. 2007 Dec;115 Suppl 1:8-14
references.pmid: 18174944
references.citation: Hum Reprod. 2008 Aug;23(8):1708-18
references.pmid: 18503055
references.citation: Genes Dev. 2000 Dec 15;14(24):3075-86
references.pmid: 11124800
references.citation: J Urol. 1979 Jul;122(1):36-9
references.pmid: 37351
references.citation: Best Pract Res Clin Endocrinol Metab. 2007 Sep;21(3):462-78
references.pmid: 17875492
references.citation: J Natl Cancer Inst. 2001 Apr 4;93(7):545-51
references.pmid: 11287449
references.citation: Obstet Gynecol Surv. 1977 Sep;32(7):611-3
references.pmid: 904793
references.citation: Obstet Gynecol. 1980 Nov;56(5):537-42
references.pmid: 7432722
references.citation: N Engl J Med. 1995 May 25;332(21):1411-6
references.pmid: 7723797
references.citation: Br J Cancer. 1988 Sep;58(3):379-81
references.pmid: 2902875
references.citation: Am J Obstet Gynecol. 1953 Nov;66(5):1062-81
references.pmid: 13104505
references.citation: JAMA. 1984 Dec 7;252(21):2984-9
references.pmid: 6502859
references.citation: Science. 1975 Dec 5;190(4218):991-2
references.pmid: 242076
references.citation: J Reprod Med. 1976 Apr;16(4):147-53
references.pmid: 772199
references.citation: Fertil Steril. 2005 Dec;84(6):1649-56
references.pmid: 16359959
references.citation: BMC Med Res Methodol. 2003 Oct 20;3:21
references.pmid: 14567763
references.citation: Am J Epidemiol. 2007 Oct 1;166(7):765-74
references.pmid: 17596265